Predictive value of motor evoked potentials in clinically isolated syndrome

Acta Neurologica Scandinavica

Volumn 124, Issue 6, 2011, Pages 410-416

  Pallix Guyot, M ^a   Guennoc, A M ^a   Blasco, H ^b   de Toffol, B ^a,b   Corcia, P ^a,b   Praline, J ^a,b  

^a CHU BRETONNEAU   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

Motor evoked potentials; Multiple sclerosis; Optic neuritis; Transcranial magnetic stimulation

Indexed keywords

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; EVOKED MUSCLE RESPONSE; FEMALE; FOLLOW UP; HUMAN; MALE; MOTOR NERVE CONDUCTION; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; PREDICTIVE VALUE; RISK ASSESSMENT; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; DEMYELINATING DISEASES; DISEASE PROGRESSION; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 80054941404     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01498.x     Document Type: Article

References (26)

1. Thrower BW. Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology 2007;68(24 Suppl. 4):S12-5.
2. Comi G. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta. Clin Ther 2009;31:1142-57.
3. Korteweg T, Tintoré M, Uitdehaag B et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006;5:221-7.
4. Tintoré M, Rovira A, Río J et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008;70(13 Pt 2):1079-83.
5. Chen R, Cros D, Curra A et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008;119:504-32.
6. Simó M, Barsi P, Arányi Z. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria. Mult Scler 2008;14:472-8.
7. Rico A, Audoin B, Franques J et al. Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2009;15:355-62.
8. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-6.
9. Currà A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A. Transcranial magnetic stimulation techniques in clinical investigation. Neurology 2002;59:1851-9.
10. Rossini PM, Barker AT, Berardelli A et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994;91:79-92.
11. Triggs WJ, Menkes D, Onorato J et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999;53:605-11.
12. Rossini PM, Berardelli A, Deuschl G et al. Applications of magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol 1999;52(Suppl):171-85.
13. Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain-stimulation the silent period after the motor evoked-potential. Neurology 1992;42:1951-9.
14. Meyer BU, Roricht S, Grafin von Einsiedel H, Kruggel F, Weindl A. Inhibitory and excitatory interhemispheric transfers between motor cortical areas in normal humans and patients with abnormalities of the corpus callosum. Brain 1995;118:429-40.
15. Riise T, Klauber MR. Relationship between the degree of individual space-time clustering and age at onset of disease among multiple sclerosis patients. Int J Epidemiol 1992;21:528-32.
16. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-8.
17. Brodsky M, Nazarian S, Orengo-Nania S et al. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 2008;65:727-32.
18. Barkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
19. Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002;346:158-64.
20. Fisniku LK, Brex PA, Altmann DR et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain 2008;3:808-17.
21. Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 2004;61:217-21.
22. Gagliardo A, Galli F, Grippo A et al. Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities. J Neurol 2007;254:220-7.
23. Haug B-A, Kukowski B. Latency and duration of the muscle silent period following transcranial magnetic stimulation in multiple sclerosis, cerebral ischemia and other upper motoneuron lesions. Neurology 1994;44:936-40.
24. Tataroglu C, Genc A, Idiman E, Cakmur R, Idiman F. Cortical silent period and motor evoked potentials in patients with multiple sclerosis. Clin Neurol Neurosurg 2003;105:105-10.
25. Caramia MD, Palmieri MG, Desiato MT et al. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clin Neurophysiol 2004;115:956-65.
26. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126(Pt 4):770-82.